We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid DNA Analysis Identifies Alleged Child Rapist

By HospiMedica staff writers
Posted on 22 Mar 2007
A new DNA testing program has led to the prompt identification and apprehension of an individual charged with raping an 11-year old girl at her Olympia, WA (USA) home late last month. More...
The first application of this rapid DNA analysis program resulted in the identification of a suspect in less than one week.

The program was implemented by the Washington State Association of Sheriffs and Police Chiefs (WASPC; WA, USA) and Orchid Cellmark (USA). The new Washington State program, made possible by special Congressional funding, is designed to ensure that DNA rape kits involving stranger rapes are analyzed within 30 days. Nationwide, DNA analysis can typically take six to twelve months, and an estimated 220,000-backlogged DNA rape kits in the United States have never been analyzed at all.

In contrast, this rapid DNA analysis program identified the alleged rapist in less than a week, leveraging good investigative work by the Olympia police force, which produced a DNA sample from a suspect that Orchid Cellmark quickly identified as belonging to the rapist. This same DNA analysis also ruled out an innocent neighbor, who had initially been charged with the crime, but who under the new program was exonerated and set free within days, not the months that could have been required in the past.

This early success in our Stranger Rape DNA Project illustrates how effective a rapid DNA analysis program can be, said Don Pierce, executive director of the WASPC, sponsor of the program. We are pleased that Washington State's Congressional delegation has helped us become the first state in the nation to implement this innovative program. By partnering with Orchid Cellmark on this project, we hope to make Washington a safer place to live.

Mark Stolorow, forensic DNA expert at Orchid Cellmark noted, As one of the largest private DNA testing labs [in the US], we have long advocated greater public/private collaboration to increase law enforcement's access to rapid DNA testing. We also had the advantage of being able to leverage our experience [in the UK], where rapid DNA testing is the norm, to design our new rapid turnaround service [in the US]. Our colleagues in Washington were the first in the nation to understand the potential of our rapid DNA testing initiative and to take action to implement it.


Related Links:
WASPC
Orchid Cellmark

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.